In the Green: Ovid Therapeutics Inc (OVID) Closes at 0.80, Up/Down -2.03 from Previous Day

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

In the latest session, Ovid Therapeutics Inc (NASDAQ: OVID) closed at $0.80 down -2.03% from its previous closing price of $0.82. In other words, the price has decreased by -$2.03 from its previous closing price. On the day, 0.59 million shares were traded. OVID stock price reached its highest trading level at $0.8765 during the session, while it also had its lowest trading level at $0.7606.

Ratios:

For a deeper understanding of Ovid Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.66 and its Current Ratio is at 5.66. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.

On April 30, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $9.

On April 29, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on April 29, 2024, with a $9 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 18 ’24 when LEVIN JEREMY M bought 18,248 shares for $2.76 per share. The transaction valued at 50,364 led to the insider holds 3,616,715 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OVID now has a Market Capitalization of 58277780 and an Enterprise Value of 9454932. For the stock, the TTM Price-to-Sale (P/S) ratio is 90.63 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 14.968 whereas that against EBITDA is -0.145.

Stock Price History:

The Beta on a monthly basis for OVID is 0.34, which has changed by -0.7325733 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, OVID has reached a high of $4.10, while it has fallen to a 52-week low of $0.68. The 50-Day Moving Average of the stock is -25.13%, while the 200-Day Moving Average is calculated to be -50.71%.

Shares Statistics:

For the past three months, OVID has traded an average of 259.47K shares per day and 349490 over the past ten days. A total of 71.01M shares are outstanding, with a floating share count of 55.62M. Insiders hold about 21.67% of the company’s shares, while institutions hold 50.80% stake in the company. Shares short for OVID as of 1734048000 were 947754 with a Short Ratio of 2.67, compared to 1731628800 on 756530. Therefore, it implies a Short% of Shares Outstanding of 947754 and a Short% of Float of 1.6199999999999999.

Most Popular